ORIGINAL ARTICLE
Clinical significance and effect of PRR 11 up-regulation on the malignancy of osteosarcoma
1
Orthopedic Center, First Affiliated Hospital, School of Medicine, Shihezi University, Shihezi, Xinjiang, China
2
Department of Pharmacy, First Affiliated Hospital, School of Medicine, Shihezi University, Shihezi, Xinjiang, China
Rui Tan and Chunbing Zhao contributed equally to this work.
Submission date: 2022-10-13
Acceptance date: 2022-10-27
Publication date: 2023-01-10
Corresponding author
Lei Chen
Lei Chen, Orthopedic Center First Affiliated Hospital School of Medicine, Shihezi University No.107 North 2nd Road Shihezi, Xinjiang 832008, China
Lei Chen, Orthopedic Center First Affiliated Hospital School of Medicine, Shihezi University No.107 North 2nd Road Shihezi, Xinjiang 832008, China
Pol J Pathol 2022;73(3):264-276
KEYWORDS
TOPICS
ABSTRACT
Osteosarcoma ranks first in both morbidity and mortality among primary bone tumors. This study aimed to investigate the effect of up-regulation of PRR11 on the malignancy of osteosarcoma and its clinical significance.
The expression, biological function, related pathways of PRR11 in osteosarcoma and its impact on prognosis were explored through the bioinformatics database. After PRR11 was up-regulated, cell proliferation, invasion, migration and apoptosis were detected by the cell counting kit-8 method, Transwell, scratch, and flow cytometry.
PRR11 is highly expressed in a variety of malignant tumors, including osteosarcoma tissue and cells, and has a significant impact on prognosis. Univariate Cox regression analysis revealed that PRR11 was an independent prognostic factor for osteosarcoma. The gene set enrichment analysis results showed that the differential genes were mainly enriched in the biological process of the cell cycle; the protein-protein interaction network mainly interacted with the regulatory genes of the cell cycle. PRR11 promotes the invasion, migration, and proliferation of osteosarcoma cells and inhibits their apoptosis.
Comprehensive bioinformatics analysis revealed that PRR11 promotes the malignancy of osteosarcoma cells mainly by participating in cell cycle regulation, and has an important impact on osteosarcoma prognosis. PRR11 may provide the basis for prognosis and treatment in patients with osteosarcoma.
The expression, biological function, related pathways of PRR11 in osteosarcoma and its impact on prognosis were explored through the bioinformatics database. After PRR11 was up-regulated, cell proliferation, invasion, migration and apoptosis were detected by the cell counting kit-8 method, Transwell, scratch, and flow cytometry.
PRR11 is highly expressed in a variety of malignant tumors, including osteosarcoma tissue and cells, and has a significant impact on prognosis. Univariate Cox regression analysis revealed that PRR11 was an independent prognostic factor for osteosarcoma. The gene set enrichment analysis results showed that the differential genes were mainly enriched in the biological process of the cell cycle; the protein-protein interaction network mainly interacted with the regulatory genes of the cell cycle. PRR11 promotes the invasion, migration, and proliferation of osteosarcoma cells and inhibits their apoptosis.
Comprehensive bioinformatics analysis revealed that PRR11 promotes the malignancy of osteosarcoma cells mainly by participating in cell cycle regulation, and has an important impact on osteosarcoma prognosis. PRR11 may provide the basis for prognosis and treatment in patients with osteosarcoma.
REFERENCES (29)
2.
Zhao X, Wu Q, Gong X, Liu J, Ma Y. Osteosarcoma: a review of current and future therapeutic approaches. Biomed Eng Online 2021; 20: 24.
3.
Tong CJ, Deng QC, Ou DJ, Long X, Liu H, Huang K. LncRNA RUSC1-AS1 promotes osteosarcoma progression through regulating the miR-340-5p and PI3K/AKT pathway. Aging (Albany NY) 2021; 13: 20116-20130.
4.
Han YL, Luo D, Habaxi K, et al. COL5A2 Inhibits the TGF-beta and Wnt/beta-Catenin Signaling Pathways to Inhibit the Invasion and Metastasis of Osteosarcoma. Front Oncol 2022; 12: 813809.
5.
Lin F, Wang X, Zhao X, Ren M, Wang Q, Wang J. Circ_0001174 facilitates osteosarcoma cell proliferation, migration, and invasion by targeting the miR-186-5p/MACC1 axis. J Orthop Surg Res 2022; 17: 159.
6.
Tang J, Zhu Z, Dong S, et al. Long non-coding RNA long intergenic non-coding 00641 mediates cell progression with stimulating cisplatin-resistance in osteosarcoma cells via microRNA-320d/myeloid cell leukemia-1 axis. Bioengineered 2022; 13: 7238-7252.
7.
Wu T, Wei B, Lin H, et al. Integral analyses of competing endogenous RNA mechanisms and DNA methylation reveal regulatory mechanisms in osteosarcoma. Front Cell Dev Biol 2021; 9: 763347.
8.
Shi D, Mu S, Pu F, et al. Integrative analysis of immune-related multi-omics profiles identifies distinct prognosis and tumor microenvironment patterns in osteosarcoma. Mol Oncol 2021.
9.
Wei K, Gao Y, Wang B, Qu YX. Methylation recognition protein YTH N6-methyladenosine RNA binding protein 1 (YTHDF1) regulates the proliferation, migration and invasion of osteosarcoma by regulating m6A level of CCR4-NOT transcription complex subunit 7 (CNOT7). Bioengineered 2022; 13: 5236-5250.
10.
Wang Y, Weng H, Zhang Y, et al. The PRR11-SKA2 bidirectional transcription unit is negatively regulated by p53 through NF-Y in lung cancer cells. Int J Mol Sci 2017; 18: 534.
11.
Hu H, Song Z, Yao Q, et al. Proline-rich protein 11 regulates self-renewal and tumorigenicity of gastric cancer stem cells. Cell Physiol Biochem 2018; 47: 1721-1728.
12.
Song D, Yang K, Wang W, Tian R, Wang H, Wang K. MicroRNA-211-5p promotes apoptosis and inhibits the migration of osteosarcoma cells by targeting proline-rich protein PRR11. Biochem Cell Biol 2020; 98: 258-266.
13.
Qin A, Reddy HG, Weinberg FD, Kalemkerian GP. Cyclin- dependent kinase inhibitors for the treatment of lung cancer. Expert Opin Pharmacother 2020; 21: 941-952.
14.
Wenzel ES, Singh ATK. Cell-cycle checkpoints and aneuploidy on the path to cancer. In Vivo 2018; 32: 1-5.
15.
Yin L, Yan J, Wang Y, Sun Q. TIGD1, a gene of unknown function, involves cell-cycle progression and correlates with poor prognosis in human cancer. J Cell Biochem 2019; 120: 9758-9767.
16.
Zhang H, Zhang X, Li X, et al. Effect of CCNB1 silencing on cell cycle, senescence, and apoptosis through the p53 signaling pathway in pancreatic cancer. J Cell Physiol 2018; 234: 619-631.
17.
Kimura K, Wakamatsu A, Suzuki Y, et al. Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes. Genome Res 2006; 16: 55-65.
18.
Zhong F, Liu S, Hu D, Chen L. LncRNA AC099850.3 promotes hepatocellular carcinoma proliferation and invasion through PRR11/PI3K/AKT axis and is associated with patients prognosis. J Cancer 2022; 13: 1048-1060.
19.
Qiao W, Wang H, Zhang X, Luo K. Proline-rich protein 11 silencing inhibits hepatocellular carcinoma growth and epithelial-mesenchymal transition through beta-catenin signaling. Gene 2019; 681: 7-14.
20.
Wang Y, Zhang C, Mai L, Niu Y, Wang Y, Bu Y. PRR11 and SKA2 gene pair is overexpressed and regulated by p53 in breast cancer. BMB Rep 2019; 52: 157-162.
21.
Zhan Y, Wu X, Zheng G, et al. Proline-rich protein 11 overexpression is associated with a more aggressive phenotype and poor overall survival in ovarian cancer patients. World J Surg Oncol 2020; 18: 318.
22.
Li K, Yu H, Zhao C, Li J, Tan R, Chen L. Down-regulation of PRR11 affects the proliferation, migration and invasion of osteosarcoma by inhibiting the Wnt/beta-catenin pathway. J Cancer 2021; 12: 6656-6664.
23.
Hau OS, Wahlin S, Cervin S, et al. PRR11 unveiled as a top candidate biomarker within the RBM3-regulated transcriptome in pancreatic cancer. J Pathol Clin Res 2022; 8: 65-77.
24.
Wang C, Yu L, Hu F, et al. Upregulation of proline rich 11 is an independent unfavorable prognostic factor for survival of tongue squamous cell carcinoma patients. Oncol Lett 2017; 14: 4527-4534.
25.
Chen N, Zhang G, Fu J, Wu Q. Identification of key modules and hub genes involved in esophageal squamous cell carcinoma tumorigenesis using WCGNA. Cancer Control 2020; 27: 1073274820978817.
26.
Gu Y, Li J, Guo D, et al. Identification of 13 key genes correlated with progression and prognosis in hepatocellular carcinoma by weighted gene co-expression network analysis. Front Genet 2020; 11: 153.
27.
Sun Y, Xu D, Zhang C, et al. HEDGEHOG/GLI modulates the PRR11-SKA2 bidirectional transcription unit in lung squamous cell carcinomas. Genes (Basel) 2021; 12: 120.
28.
Zhou L, Deng ZZ, Li HY, et al. Overexpression of PRR11 promotes tumorigenic capability and is associated with progression in esophageal squamous cell carcinoma. Onco Targets Ther 2019; 12: 2677-2693.
29.
Wang C, Yu L, Ren X, et al. The oncogenic potential of PRR11 gene in tongue squamous cell carcinoma cells. J Cancer 2019; 10: 2541-2551.
| eISSN: | 2084-9869 |
| ISSN: | 1233-9687 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
